Searched for
GENERIC ADVAIR DISKUS
Aurobindo Pharma launches generic Advair Diskus for asthma and COPD in USLannett Company, part of Aurobindo Pharma, has launched generic Advair Diskus in the US, making it the first complex inhalation product fro...- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- Cipla sticks to 21-22% operating profit guidance for FY23, posts Rs 789 crore profit in Q2Cipla reported a multi-quarter high of $179 million in revenue and 25% YoY growth led by the successful launch of a generic version of the ...
- Cipla submits application with USFDA for generic version of asthma drugDrug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK's Advair Diskus, ...
- Cipla to raise Rs 3,000 crore, Q4 net misses Street view: Key takeawaysIt had posted a net profit of Rs 357.68 crore in the same quarter a year ago.
- Cipla jumps 8% on completing Phase-3 clinical study of asthma drugThe generic would be used for treatment of asthma and chronic obstructive pulmonary disease.
- Lupin launches asthma drug delivery device in USThe agreement grants Lupin exclusive rights to promote, distribute and market InspiraChamber VHC in the US, it added.
- Sensex rallies over 150 points, Nifty reclaims 8850; top 12 stocks in focusNifty also managed to reclaim its crucial psychological level of 8850, supported by gains in capital goods, consumer durable, FMCG and real...
- Twelve stocks in focus in Wednesday morning tradeIndian markets are expected to trade in a range. Here is a list of twelve stocks which are likely to be in focus today.
- Lupin ties up with Poland-based firm for generic asthama drugLupin has set up a dedicated centre of excellence for inhalation research in Florida after having hired top notch inhalation scientists las...
Load More
